GammaDelta Therapeutics' Corporate Minority Round

GammaDelta Therapeutics raised a round of funding on May 09, 2017. Investors include Takeda Pharmaceutical.

GammaDelta Therapeutics is an immunotherapy company developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exp…

Articles about GammaDelta Therapeutics' Corporate Minority Round: